The largest database of trusted experimental protocols

17 protocols using recombinant murine rankl

1

Murine Osteoclastogenesis Assay with Exosomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine BMMs at a density of 1 × 106 cells/ml or RAW264.7 cells at a density of 1 × 105 cells/ml were plated in a chamber slide (Thermofisher, Waltham, MA, USA) and cultured in complete α-MEM supplemented with 50 ng/ml murine recombinant M-CSF, 25 ng/ml murine recombinant RANKL (Peprotech, Rocky Hill, NJ, USA) in the presence or absence of 20 μg/ml exosomes, a concentration used previously in multiple studies27 (link),66 (link),81 (link),82 (link). On day 4, TRAP staining was performed using a leukocyte acid phosphatase kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer’s instructions. The multinucleated TRAP-positive cells from five biological replicates were considered mature OC cells and monitored by Zeiss Axioplan2 microscope. The size of OC cells was measured by ImageJ as reported83 (link).
+ Open protocol
+ Expand
2

High Glucose Effects on Osteoclastogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RAW264.7 murine monocytic cell line was purchased from KeyGEN Biotech Co., Ltd. (Nanjing, China). The cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 5.6 mM D-glucose (Hyclone, Logan, UT, USA) supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin and 10% fetal bovine serum (FBS; Hyclone), and incubated at 37°C in 5% CO2 humidified air. To investigate the effect of high glucose on osteoclastogenesis, the cells were seeded at a density of 1×105 cells/well in 6-well plates, 2×104 cells/well in 24-well plates and 5×103 cells/well in 96-well plates, and cultured in DMEM with different doses (5.6 and 20.2 mM) of D-glucose or DMEM with mannitol (14.6 mM; Bio Science Technology. Co., Ltd., Shanghai, China) added at 37°C in 5% CO2 humidified air for 4 or 5 days. Following attachment of the cells, 100 ng/ml murine recombinant RANKL (PeproTech, Rocky Hill, NJ, USA) was added to the different mediums to generate osteoclasts. The cells cultured with 5.6 mM glucose in the absence of RANKL were defined as the untreated group, those cultured with 5.6 mM glucose in the presence of RANKL were defined as the control group, those cultured with 20.2 mM glucose were defined as the high glucose group and those cultured with mannitol were defined as the osmotic control group.
+ Open protocol
+ Expand
3

Exosomal miR-19a Modulates Osteoclast Bone Resorption

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the role of exosomal miR-19a in the bone resorption activity of OC cells, pit assay was performed on bone slices (Immunodiagnostic Systems). 50,000 bone marrow-derived OC precursor BMMs were seeded on sterilized bone slices placed in a 96-well plate. The BMMs were cultured with complete α-MEM supplemented with 50 ng/ml murine recombinant M-CSF, 25 ng/ml murine recombinant RANKL (Peprotech, Rocky Hill, NJ, USA) in the presence or absence of 20 μg/ml exosomes. The media was changed every 2–3 days. After two weeks of cell culture, cells were washed, and resorption pits were stained with 1% toluidine blue. The resorption area was photographed under microscopy and the image was analyzed by ImageJ.
+ Open protocol
+ Expand
4

Modulation of Osteoclastogenesis by Alpha-Ketoglutarate Derivatives

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alpha-ketoglutaric acid (AKG) disodium salt, dimethyl alpha-ketoglutarate (DM-AKG), and dimethyl oxalylglycine (DMOG) were purchased from Sigma-Aldrich. Recombinant murine RANKL and M-CSF were purchased from Peprotech (Rocky Hill, NJ, USA). Antibodies for phospho-IKKα/β, IKKβ, phospho-IκBα, IκBα, NF-κB (P65), histone H3, and β-actin were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies for PHD1, PHD2, and PHD3 were purchased from Abcam (Billerica, MA, USA). The RAW264.7 cell line was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Dulbecco’s Modified Eagle’s Medium (DMEM), α-minimum essential medium (α-MEM), fetal bovine serum (FBS), penicillin, and streptomycin were purchased from Gibco (Rockville, MD, USA).
+ Open protocol
+ Expand
5

Osteoclastogenesis Regulation by Artemether

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fetal bovine serum (FBS) and alpha modification of Eagle medium (α-MEM) were purchased from Gibco (Sydney, Australia). The cell counting kit (CCK-8) was obtained from Dojindo Molecular Technologies (Kumamoto, Japan). Recombinant murine M-CSF and recombinant murine RANKL were purchased from PeproTech (Rocky Hill, USA). Primary antibodies against ERK, phospho-ERK (Thr202/Tyr204), JNK, phospho-JNK (Thr183/Tyr185), p38, phospho-p38 (Thr180/Tyr182), p65, phospho-p65 (Ser536), IκBα, phospho-IκBα (Ser32), Akt, phospho-Akt(Ser473), transforming growth factors-β-activated kinase 1 (TAK1), phosphor-TAK1 (Ser412), MAP kinase kinase 1/2 (MEK1/2), phospho-MEK1/2 (Ser217/221), MAP kinase kinase 3/6 (MKK3/6), phospho-MKK3(Ser189)/6(Ser207), MAP kinase kinase 7 (MKK7), phospho-MKK7 (Ser271/Thr275), NFATc1/NFAT2, β-actin, and HRP-linked secondary antibodies against mouse or rabbit IgG were purchased from Cell Signaling Technology (Danver, MA, USA). Primary antibody against c-Fos was purchased from Abcam (Cambridge, MA). The TRAP staining kit, DMSO, and LPS were purchased from Sigma-Aldrich (St. Louis, USA). Artemether was purchased from Tauto Biotech (Shanghai, China).
+ Open protocol
+ Expand
6

Osteoclastogenesis Assay with LPS and MTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPS from E. Coli serotype 055:B5 and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma Aldrich (St. Louis, MO, United States). As TRAP staining reagent, Acid phosphatase Kit 387-A was used (Sigma-Aldrich, St. Louis, MO, United States). TRAP reaction buffer was prepared as described by the manufacturer’s instructions (Sigma Aldrich, St. Louis, MO, United States). Recombinant murine RANKL was from Peprotech (PeproTech EC, Ltd., London, United Kingdom). pSrc/Src ratio was assessed by immunoblot with rabbit Phospho-Src Family (Tyr416) Antibody #2101 (Cell Signaling Technology, Danvers, MA, USA), recognizing the phosphorylation at tyrosine 424 in murine c-Src, followed by the detection of total Src by rabbit monoclonal antibody 36D10 (Cell Signaling Technology, Danvers, MA, United States), as previously shown (Manni et al., 2020 (link)).
+ Open protocol
+ Expand
7

Osteoclastogenesis Inhibition by CoCrMo Particles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paeoniflorin agent (lot no. 75603) and tartrate-resistant acid phosphatase (TRAP) staining kits were purchased from Sigma-Aldrich (St. Louis, MO, USA). Recombinant murine RANKL and murine colony stimulating factor (M-CSF) were purchased from PeproTech (Rocky Hill, NJ, USA). All antibodies used in this research were purchased from the Cell Signaling Technology (Boston, MA, USA). The CoCrMo particles were purchased from Zimmer Medical Group (Warsaw, IN, USA) with an average diameter of 100 nm, which is similar to clinical wear particle size. Particles were washed in a 70% ethanol solution to remove bound endotoxin and determined to be endotoxin-free using the Limulus assay (Endosafe, Charles Rivers, Charlestown, SC, USA). The particles were suspended in sterile phosphate-buffered saline (PBS) at a concentration of 0.1 mg/μL for further experiments. Scanning electron microscopy (SEM) was carried out to characterize the size of particles (S3400I, Hitachi, Japan).
+ Open protocol
+ Expand
8

Osteoclastogenesis Regulation Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant murine RANKL and M-CSF were supplied by Peprotech (Rocky Hill, NJ, USA). Phospho-IκBα, IκBα, phospho-JNK, JNK, p38, phospho-p38, ERK, phospho-ERK, STAT3, and phospho-STAT3 antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies against NFATc1, c-Fos and β-actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). NTZ with purity greater than 99% was purchased from Selleck Chemicals (Shanghai, China).
+ Open protocol
+ Expand
9

Isolation and Culture of Primary Mouse BMDM and AM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mouse BMDM or AM were prepared from 8 to 10-week-old female C57BL/6J mice. BMDM were isolated with a monocyte isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) following the manufacturer’s instructions. AM were collected from BALF as described above. BMDM and AM were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) + 10% heat-inactivated fetal bovine serum (FBS) supplemented with 20 ng/ml recombinant murine M-CSF (PeproTech, Rocky Hill, NJ) and 2 ng/ml recombinant murine RANKL (PeproTech). Medium was changed every 2 to 3 days. At day 3 or day 7 of culture, total RNA was purified from cells for RT-PCR analysis.
+ Open protocol
+ Expand
10

Osteoclast Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264.7 cells were cultured in 96-well plates at 3 × 103 cells and treated with 50 ng/mL of recombinant murine RANKL (PeproTech Inc., Rocky Hill, NJ) as positive control or cell culture supernatant of MC3T3-E1 stimulated by zymosan-mediated complement activation. After 5 days, cells were fixed in 4% paraformaldehyde for 30 min and then stained for the osteoclast enzyme maker, tartrate-resistant acid phosphatase (TRAP) activity according to the manufacturer’s instructions (Sigma). In our study, TRAP-positive multinucleated cells (nuclei >3) were defined as osteoclasts using a light microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!